Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProton Mtr Pwr Regulatory News (PPS)

  • There is currently no data for PPS

New Loan Facility

28 Jun 2024 07:00

RNS Number : 2363U
Proton Motor Power Systems PLC
28 June 2024
 

 

 

28 June 2024

 

Proton Motor Power Systems plc

("Proton" or the "Company")

 

New Loan Facility

 

Proton Motor Power Systems plc (AIM: PPS), the designer, developer and producer of fuel cells and fuel cell electric hybrid systems with a zero carbon footprint, announces that it has entered into a new €12 million loan facility with Mr. Falih Nahab (the "2024 Falih Nahab Facility").

 

The 2024 Falih Nahab Facility has been provided on the same terms as the existing €77.5 million loan facility with Mr. Falih Nahab. The 2024 Falih Nahab Facility has an interest rate of 12 months EURIBOR + 3%. The interest accrued on the 2024 Falih Nahab Facility can be settled once or twice yearly by way of an issue of ordinary shares of 0.5 pence each in Proton Motor Power Systems PLC ("Ordinary Shares") to Mr. Nahab with such shares being issued at the prevailing market price of an Ordinary Share at the time of issue and subject to there being no closed period at the time of issue.

 

The principal amount on the 2024 Falih Nahab Facility, along with any accrued interest, is repayable on 31 December 2025.

 

The loan facilities provided to the Company by Falih Nahab and SFN Cleantech Investment Limited ("SFN") have consistently enabled the Company to progress the development and commercialization of its hydrogen product offer, without the need to issue further equity. The 2024 Falih Nahab Facility is expected to allow the Company to satisfy its working capital needs until at least June 2025. However, it should be noted that the Company does not currently expect to generate net free cash by that time and therefore may require additional funding for its future working capital needs.

 

Related Party Transaction

Mr. Falih Nahab is a substantial shareholder (as defined in the AIM Rules for Companies). The entry into the 2024 Falih Nahab Facility is therefore classified as transaction with a related party for the purposes of the AIM Rules for Companies. The directors of the Company, with the exclusion of Dr. Faiz Nahab, the Company's Chief Executive, who is the brother of Mr. Falih Nahab, having consulted with the Company's nominated adviser, Allenby Capital Limited, consider that the entry into the 2024 Falih Nahab Facility is fair and reasonable insofar as the Company's shareholders are concerned.

 

For further information:

 

Proton Motor Power Systems Plc

Dr Faiz Nahab, CEO

Ali Naini, Chairman

Roman Kotlarzewski, CFO

Antonio Bossi, Non-Executive Director

 

+49 (0) 173 189 0923

 

 

 

Investor relations:

www.protonpowersystems.com

investor-relations@proton-motor.de

 

Allenby Capital Limited

Nominated Adviser & Broker

James Reeve / Vivek Bhardwaj

 

+44 (0) 20 3328 5656

Celicourt Communications

PR Adviser

Mark Antelme / Philip Dennis /

Charlie Denley-Myerson

 

 +44 (0) 20 7770 6424 / protonmotor@celicourt.uk

 

 

About Proton Motor Fuel Cell GmbH

 

Proton Motor has 25 years of experience in Power Solutions using CleanTech technologies such as hydrogen fuel cells, fuel cell and hybrid systems with a zero carbon footprint. Based in Puchheim near Munich, Proton Motor develops and produces standard Products as well as customised solutions. The focus of Proton Motor is on stationary solutions, as well as mobile, marine and rail applications. The product portfolio consists of base-fuel cell systems, standard complete, as well as customised systems.

 

Proton Motor Fuel Cell GmbH is a wholly owned subsidiary of Proton Motor Power Systems plc. The Company has been quoted on the AIM market of the London Stock Exchange since October 2006 (code: PPS).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDQDLFLZQLLBBB
Date   Source Headline
3rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 20202:06 pmRNSSecond Price Monitoring Extn
3rd Jun 20202:01 pmRNSPrice Monitoring Extension
1st Jun 20204:42 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
21st May 20204:40 pmRNSSecond Price Monitoring Extn
21st May 20204:36 pmRNSPrice Monitoring Extension
6th May 20207:00 amRNSEmployee Share Scheme
16th Apr 20207:00 amRNSNo negative COVID-19 impact on Proton
7th Apr 20207:00 amRNSDirector/PDMR Shareholding
23rd Mar 20202:45 pmRNSHolding(s) in Company
16th Mar 202011:06 amRNSSecond Price Monitoring Extn
16th Mar 202011:00 amRNSPrice Monitoring Extension
12th Mar 20209:15 amRNSNew Order
10th Mar 20204:41 pmRNSSecond Price Monitoring Extn
10th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20201:58 pmRNSFramework agreement
6th Mar 20205:20 pmRNSDirector/PDMR Shareholding
2nd Mar 20204:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20204:36 pmRNSPrice Monitoring Extension
28th Feb 202010:48 amRNSEmployee Share Scheme
27th Feb 20202:05 pmRNSSecond Price Monitoring Extn
27th Feb 20202:00 pmRNSPrice Monitoring Extension
24th Feb 20207:00 amRNSDirector/PDMR Shareholding
21st Feb 20202:59 pmRNSDirector/PDMR Shareholding
13th Feb 20203:00 pmRNSDirector dealing and exercise of Share options
10th Feb 202011:35 amRNSDirectors dealings and issue of equity
4th Feb 20202:18 pmRNSNew order
30th Jan 20207:00 amRNSDirector/PDMR Shareholding
27th Jan 20204:10 pmRNSDirector/PDMR Shareholding
22nd Jan 20201:49 pmRNSNew order
22nd Jan 202011:05 amRNSSecond Price Monitoring Extn
22nd Jan 202011:00 amRNSPrice Monitoring Extension
21st Jan 20204:17 pmRNSDirector/PDMR Shareholding
20th Jan 20209:05 amRNSSecond Price Monitoring Extn
20th Jan 20209:00 amRNSPrice Monitoring Extension
17th Jan 20207:00 amRNSDirector/PDMR Shareholding
16th Jan 20207:00 amRNSExercise of options and total voting rights
13th Jan 20203:15 pmRNSDirector/PDMR Shareholding
10th Jan 202011:00 amRNSDirector/PDMR Shareholding
6th Jan 20208:10 amRNSDirector/PDMR Shareholding
2nd Jan 20208:37 amRNSDirector/PDMR Shareholding
24th Dec 20197:00 amRNSDirector/PDMR Shareholding
23rd Dec 20197:00 amRNSDirector/PDMR Shareholding
23rd Dec 20197:00 amRNSIssue of Equity and Directors' Dealing
20th Dec 20194:14 pmRNSDirector/PDMR Shareholding
17th Dec 201911:59 amRNSChange of Name
16th Dec 20192:18 pmRNSResult of Meeting and proposed change of name
12th Dec 20191:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.